Health AI Central
Share:
Peer-Reviewed Publication
Comput Methods Programs Biomed2021;209106319.September 1, 2021Journal Article

Introduction of digital therapeutics.

Ji Sun Hong1, Chris Wasden2, Doug Hyun Han3
1Department of Psychiatry, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Republic of Korea. Electronic address: jisunhong925@naver.com.
2HappifyDTx, Happify Health. Electronic address: chris@happify.com.
3Department of Psychiatry, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Republic of Korea. Electronic address: hduk@cau.ac.kr.
PubMed DOI

Abstract

BACKGROUND AND OBJECTIVES: Digital therapeutics are an emerging type of medical therapy and are defined as evidence-based therapeutic interventions for patients by means of qualified software programs to prevent, manage, or treat medical conditions. Today, digital therapeutics products are on the market or under development for a wide range of medical conditions such as diabetes, oncology treatmen…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.